Comerica Bank’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$5.89K 3738
2024
Q3
$5.89K Hold
200
﹤0.01% 3288
2024
Q2
$2.47K Hold
200
﹤0.01% 3455
2024
Q1
$4.06K Hold
200
﹤0.01% 3379
2023
Q4
$4.5K Hold
200
﹤0.01% 3346
2023
Q3
$3.33K Buy
+200
New +$3.96K ﹤0.01% 3466

Other funds holding FLNA

Comerica Bank's FLNA Position: Q4 2024 in Review

Comerica Bank sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 200 shares — an estimated $5.89K sold.

Comerica Bank first reported a position in FLNA in Q3 2023 and held it in 5 quarters. The position peaked at $5.89K in Q3 2024. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Comerica Bank reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Comerica Bank sold 200 Filana Therapeutics shares in Q4 2024, an estimated $5.89K.
  • Comerica Bank first reported a position in Filana Therapeutics in Q3 2023 and held it in 5 quarters.
  • Comerica Bank's Filana Therapeutics position peaked at $5.89K in Q3 2024.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Comerica Bank's 13F filing for Q4 2024, filed 14 Feb 2025.